Related Experiment Video
Updated: Dec 22, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
H Matsue1, K Matsue, M Walters
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas 75235-9069, USA.
Insights
Researchers developed
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Dendritic cells (DCs) are key antigen-presenting cells.
- DCs typically activate naive T cells.
- T cell activation is central to immune responses.
Purpose of the Study:
- To investigate the immunomodulatory potential of DCs engineered to express CD95 ligand (CD95L).
- To explore the use of these modified DCs, termed 'killer' DCs, for immune suppression.
Main Methods:
- Transfection of DCs with CD95L cDNA to create 'killer' DCs.
- Antigen pulsing of killer DCs.
- Administration of killer DCs to mice before and after sensitization.
- Assessment of immune responses upon subsequent challenge.
Main Results:
- Killer DCs induced T cell death instead of activation after antigen-specific interaction.
- Pre-sensitization administration of killer DCs led to antigen-specific immunosuppression.
- Post-sensitization administration of killer DCs almost completely suppressed immune responses.
Conclusions:
- Engineered 'killer' DCs offer a novel approach to immune modulation.
- This strategy shows potential for preventing and treating T cell-mediated inflammatory diseases.
- Killer DCs represent a new immunomodulatory protocol with therapeutic implications.
Abstract:
Dendritic cells (DCs) are special subsets of antigen-presenting cells characterized by their highly potent capacity to activate immunologically naive T cells. Here we report that DCs that are transfected with CD95 ligand (CD95L) cDNA, called 'killer' DCs, deliver death signals, instead of activation signals, to T cells after antigen-specific interaction. Injection of antigen-pulsed killer DCs into mice before sensitization induced antigen-specific immunosuppression. When administered after sensitization, killer DCs suppressed immune responses almost completely after subsequent challenge. Thus, killer DCs represent an entirely new immunomodulatory protocol, which may become directly applicable in preventing and even treating T cell-mediated inflammatory diseases.
More Related Videos
Related Concept Videos
06:18Pioneering Patient-Specific Approaches for Precision Surgery Using Imaging and Virtual Reality
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
11:27Magnetically-Assisted Remote Controlled Microcatheter Tip Deflection under Magnetic Resonance Imaging
06:24Mouse Models of Periventricular Leukomalacia

